bpc-157 human clinical trials evidence review safety regulatory status BPC- 157 Are there concerns with the

Don't ask me about it, but like, there are these research chemicals which are available, like, I don't know, like it's all very legally, it's very gray

This article is intended for general informational purposes only and does not address individual circumstances

This medicine has shown hopeful safety profiles in animal studies and early clinical trials for different diseases, however, its safety for managing ED in humans is not well-established

[4] Pharmacokinetics and Distribution Pharmacokinetic work in mice reported systemic exposure and distribution of 5-Amino-1MQ to metabolically active tissues, including adipose, muscle, and liver, after subcutaneous compound application

For B6, the needs are: Infants 0-6 months: 0.1 mg Infants 7-12 months: 0.3 mg Children 1-3 years: 0.5 mg Children 4-8 years: 0.6 mg Males 9-13 years: 1.0 mg Males 14-50 years and above: 1.3-1.7 mg Females 9-13 years: 1.0 mg Females 14-18 years: 1.2 mg Females 19-50 years: 1.3 mg Pregnant women: 1.9 mg Breastfeeding women: 2.0 mg For B12, the needs are: Infants 0-6 months: 0.4 mcg Infants 7-12 months: 0.5 mcg Children 1-3 years: 0.9 mcg Children 4-8 years: 1.2 mcg Children 9-13 years: 1.8 mcg Adults: 2.4 mcg Pregnant women: 2.6 mcg Breastfeeding women: 2.8 mcg Therapeutic Dosages for Specific Conditions For some health issues, more of vitamins B6 and B12 might be needed

They are not approved to diagnose, treat, cure, or prevent any disease